ArticleLa Tunisie medicale2023
Article in La Tunisie medicale, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDespite the spread of COVID-19 in Tunisia and its impact on people, health and economy, few studies have investigated the profile of COVID-19 Tunisian patients.
aimDetermine the epidemiological, clinical, para-clinical and therapeutic characteristics patients and identify the associated factors of severity.
methodsThis is a retrospective study, conducted among confirmed COVID-19 patients consulting the hospital emergency department. We collected Data using from the patients' computerized files. We performed Data entry and analysis using SPSS 22.
resultsWe included 375 patients. The average age was 66.7±11.43 years with a sex ratio of 1.6. The most frequent comorbidities were diabetes (100%), hypertension (64.5%), and chronic heart disease (25.9%). The most frequent clinical signs were dyspnea (75.2%), asthenia (66.9%), cough (66.7%) and fever (60.3%). The most frequent biological abnormalities were biological inflammatory syndrome (96%) and elevation of troponin (69.3%). CT scans revealed lung damage in 34.1% of patients. As for treatments, 91.7% received antibiotics, 89% received corticosteroids, 89.3% received anticoagulants, and 85.1% received ventilation (42.6% non-invasive ventilation and 1.9% were intubated). Risk factors of severity were age, chronic heart disease and hypertension.
conclusionKnowing the particularities of Tunisian patients will help to install recommendations to improve the process of care and prevention.
Indexed as
Identifiers
38372540PMC11217966What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.